HEPCVIR L Tablet
International name: Harvoni (Sofosbuvir + Ledipasvir)
Name of generic: HEPCVIR-L
Manufacturer: Cipla Ltd.
Dosage: 400/90 mg
Type of packaging: can 28 tablets
HEPCVIR-L – a real bestseller against HCV from CIPLA (INDIA), an inhibitor of RNA polymerase, is approved for the treatment of patients infected with hepatitis C virus 1 and 4 genotype. HEPCVIR-L is the first FDA-approved therapy for the treatment of HCV, in which no collateral is assigned to the drug COPEGUS or short interferons. HEPCVIR-L is the official generic of Harvoni and produced in India under a patent of the copyright holder that proves its full pharmaceutical bioequivalence with the original Harvoni.
During long-term clinical studies have been proved not only by the high activity of Harvoni against the virus, but also its remarkably low toxicity. The study involved more than 1650 patients with viral hepatitis C 1 genotype. The course of treatment lasted only 84 days. At the end of therapy in 1600 patients have achieved their initial aim of treatment is the absence of the virus. Side effects that occurred because of reception of Harvoni (sofosbuvir + ledipasvir) were not clearly expressed and were accompanied mainly headache and fatigue.
FOR THE TREATMENT OF HEPATITIS C YOU CAN WHATSAPP/ VIBER US – +919555604444
Or email us at firstname.lastname@example.org
How to Buy Hepcvir L tablet from India, learn about the availability of drugs, Online price of Hepcvir L tablet in India and order delivery?
You can get answers to all your questions by submitting an inquiry on our product page.